Pharmatalkradio

Pfizer’s “Blue Sky” approach to transforming clinical research in Parkinson’s disease is an inspiring example of patient-centric innovation. Conference Forum's, Valerie Bowling welcomes co-host, Ed Miseta, Clinical Leader.com in a discussion with members of Pfizer’s "Blue Sky" team. Together they discuss the vision, goals and journey in taking a new approach to advancing drug development. More specifically, the Blue Sky team talks about their partnership with IBM, (first of its kind) decisions on how to use a device in a trial, real time data collection, an 1800s house for a 21st Century research and more.  Co-Hosts:  Valerie Bowling, Executive Director, The Conference Forum Ed Miseta, Chief Editor, Clinical Leader and Contributing Writer, Life Science Leader Guests:  Stephen Amato, PhD, Project Manager, BlueSky, Pfizer David Caouette, MBA, Senior Director, Strategy and Operations Lead, BlueSky and Quantitative Medicine, Pfizer    Daniel Karlin, MD, Senior Director, Quantitative Medicine, Clinical Lead